BARCELONA, June 14 (Reuters) - UCB SA's experimental arthritis treatment Cimzia could be priced at a discount to rivals, since the drug has lower production costs, a key scientific investigator on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback